About Hooke Laboratories
First class science at competitive prices
At Hooke, we are working to be the leading company providing tools for in vivo research.
Our 100% focus on rodent in vivo research allows us to introduce innovations that make animal research more efficient and less expensive, with the goal of accelerating cures for human diseases while reducing and refining the use of animals.
The company was founded by immunologist Suzana Marusic, MD, PhD.
Hooke Laboratories is named after Robert Hooke, F.R.S. (1635-1703), the world’s first professional scientist and discoverer of the cell.
Management Team
Suzana
Marusic, M.D., Ph.D.
President and CEO
Suzana Marusic directs the company’s contract research and reagent products efforts. Before founding Hooke, she headed the Laboratory for Inflammatory Target Validation at Wyeth Pharmaceuticals in Cambridge MA, where she led basic research in asthma and experimental autoimmune encephalomyelitis, developed new mouse models of asthma and EAE and led in vivo validation and testing of an array of potential therapeutics. Her expertise includes T-cell development, cellular immune responses, mechanisms of peripheral tolerance, immune-mediated diseases and oncology. Prior to joining Wyeth in 1998, Suzana was a postdoctoral fellow in the lab of Nobel laureate Susumu Tonegawa at MIT and in the lab of Dr Ada Kruisbeek at NIH. She was a visiting scientist at the Max Plank Institute in Tübingen, Germany, and Associate Professor and Head of Lab for Molecular and Cellular Immunology at Institut Ruđer Bošković, Zagreb, Croatia. Dr Marusic is a reviewer for multiple scientific journals and is the author of over 30 papers published in journals including the Journal of Experimental Medicine, Journal of Immunology, and Nature.
Dave
Lindbergh
Executive Vice President
Dave Lindbergh leads the company’s development of laboratory instrumentation systems that will help in vivo scientists with their work. Prior to joining Hooke, Dave was Director of Standardization at Polycom, Inc., where he was active in international telecommunications standardization, including Committee T1, TIA, IETF, ISO/IEC and ITU, where he served as Rapporteur for ITU-T Study Group 16 Question 23 (“Media Coding”), as a principal contributor to ITU-T Recommendations H.223, H.224, H.281, H.460.18, H.460.19 and V.140, as editor for Recs. H.226, H.239, H.241, and H.324, and as chairman of the H.324 Systems Experts, H.264 Requirements, and H.264 Applications groups. Dave also served on the Board of Directors of the International Multimedia Telecommunications Consortium (IMTC), as chairman of its Requirements WG and co-chair of its Media Processing and IPR activity groups. He is a co-author of Digital Compression for Multimedia: Principles and Standards (Morgan Kaufmann, 1998), and a contributor to Multimedia Communications (Academic Press, 2001) and the Wiley Encyclopedia of Telecommunications (John Wiley & Sons, 2002). In 2002 he received an IMTC Leadership Award for his contributions to the standardization community. In 1981 Dave founded Lindbergh Systems, maker of OMNITERM data communications software.
News & Press
2008 April 14 - Pre-Characterized Hooke Kits™ Eliminate Tedious Emulsion Preparation, Induce EAE and CIA
_150px.jpg)